Dr. Mark D. Tyson II, MD

Dr. Tyson practices at Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona.

Dr. Tyson's NPI, 1346568508, was assigned on May 12, 2010. Dr. Tyson graduated from Geisel School Of Medicine At Dartmouth in 2010. Dr. Tyson holds Arizona license 44610.

Dr. Tyson's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale, at 13400 East Shea Boulevard, Scottsdale, AZ 85259. The practice phone is (480) 342-4201.

Dr. Tyson's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona. Dr. Tyson is also affiliated with Mayo Clinic Hospital - Phoenix. The medical group on file is Mayo Clinic Arizona. Dmand AI also links Dr. Tyson to 3 more home health agencies, each named with a free account. Dr. Tyson's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tyson practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Tyson's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Tyson is board certified in urology by the American Board of Urology. Dmand AI has Dr. Tyson's licenses on file in 7 states: Arizona, New Mexico, Colorado, California, Idaho, Nevada and Tennessee.

Dmand AI lists bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney removal surgery, prostate cancer, prostate surgery, transurethral procedures and urinary endoscopy among the conditions Dr. Tyson treats.

CMS data shows 5,246 Medicare services from Dr. Tyson across 28 procedure codes in 2024, for 980 Medicare patients. Medicare paid $221,175 for them.

CMS counts 980 Medicare patients who saw Dr. Tyson in 2024. The largest group is 75 to 84, with 452 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tyson's median patient age at 74, with 23% women.

In 2024, Dr. Tyson wrote 21 Medicare Part D claims. 81% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $275 in total drug cost. In 2020, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Tyson for performance year 2024, reported as part of a group. Dr. Tyson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tyson as offering telehealth. CMS counts 35 procedures of prostate resection by Dr. Tyson, more than 93% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 114 papers to Dr. Tyson, published from 2006 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Urinary Bladder Neoplasms, Cystectomy and Prostatic Neoplasms. Dr. Tyson has published most often in J Urol. Dr. Tyson's most frequent co-authors are Mitchell R. Humphreys, MD, Erik Peter Castle, MD and Adri Durant, MD.

Dmand AI links Dr. Tyson to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Non-Muscle Invasive Bladder Neoplasms and Urinary Bladder Neoplasms.

CMS Open Payments shows 78 general payments to Dr. Tyson from 19 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 84% of the total. Ferring Pharmaceuticals Inc. paid the most, $16,558.

Dmand AI lists 16 awards for Dr. Tyson, most recently Chief Debate Winner in 2015.

Dr. Tyson graduated from Geisel School Of Medicine At Dartmouth in 2010.

Dr. Tyson is in network with 6 carriers, including United Healthcare, Aetna and Blue Cross and Blue Shield of Kansas City. PPO plans come from the most carriers, 3. Check the plan with the practice before a visit.